These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11875863)

  • 1. [Comparison of predictive values of inhibins A and B, and plasma estradiol in IVF patients treated with GnRH agonists and recombinant FSH].
    Millot F; Antoine JM; Merviel P; Mathieu E; Carpeau J; Uzan S
    Gynecol Obstet Fertil; 2002 Jan; 30(1):36-41. PubMed ID: 11875863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.
    Miao MF; Huang HF
    J Zhejiang Univ Sci B; 2009 Jan; 10(1):35-45. PubMed ID: 19198021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders.
    Eldar-Geva T; Margalioth EJ; Ben-Chetrit A; Gal M; Robertson DM; Healy DL; Diamant YZ; Spitz IM
    Hum Reprod; 2002 Sep; 17(9):2331-7. PubMed ID: 12202421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer.
    Lockwood GM; Muttukrishna S; Groome NP; Knight PG; Ledger WL
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):741-8. PubMed ID: 9039341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gonadotrophins with differing LH/FSH ratios on the secretion of the various species of inhibin in women receiving IVF.
    Fawzy M; Harrison RF; Knight PG; Groome N; Anderson A; Robertson WR; Lambert A
    Hum Reprod; 2001 Jun; 16(6):1092-7. PubMed ID: 11387274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
    Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
    J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J; Balasch J; Fábregues F; Carmona F; Casamitjana R; Moreno V; Calafell JM; Vanrell JA
    Hum Reprod; 2000 Jul; 15(7):1499-504. PubMed ID: 10875856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP; Laven JS; de Jong FH; Fauser BC
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.
    Eldar-Geva T; Robertson DM; Cahir N; Groome N; Gabbe MP; Maclachlan V; Healy DL
    J Clin Endocrinol Metab; 2000 Feb; 85(2):607-13. PubMed ID: 10690863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome.
    Hall JE; Welt CK; Cramer DW
    Hum Reprod; 1999 Feb; 14(2):409-15. PubMed ID: 10099988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.
    Seifer DB; Lambert-Messerlian G; Hogan JW; Gardiner AC; Blazar AS; Berk CA
    Fertil Steril; 1997 Jan; 67(1):110-4. PubMed ID: 8986693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment.
    Casper FW; Seufert RJ; Schaffrath M; Pollow K
    Fertil Steril; 2001 Jan; 75(1):32-7. PubMed ID: 11163813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.